XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 6 - Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Asset Impairment Charges [Text Block]

NOTE 6 - Goodwill and Intangible Assets:

 

Goodwill

 

Beginning in the second quarter of 2022, the Company realigned its reportable segments to Branded Products, Healthcare Apparel and Contact Centers. Refer to Note 17 for further information on the Company’s reportable segments. As a result of this re-segmentation, and in accordance with ASC 350, the Company performed a quantitative goodwill impairment test.

 

During the third quarter of 2022, the Company determined that a triggering event occurred in relation to the depressed market price of the Company’s common stock and corresponding significant decline in the Company’s market capitalization. As a result, the Company performed a quantitative goodwill impairment test.

 

The fair value of goodwill in each impairment test was determined using a combination of an income approach, which estimates fair value based upon projections of future revenues, expenses, and cash flows discounted to their respective present values, and a market approach. The valuation methodology and underlying financial information included in the Company’s determination of fair value required significant judgments by management. The principal assumptions used in the Company’s discounted cash flow analysis consisted of (a) long-term projections of financial performance and (b) the weighted-average cost of capital of market participants, adjusted for the risk attributable to the Company and the industry in which it operates. Under the market approach, the principal assumption included an estimate of a control premium.

 

Based on the goodwill impairment analysis performed, the Company determined that the estimated fair values of the previous Uniforms and Related Products segment and current Branded Products segment were lower than their carrying value primarily as the result of current market conditions, decline in expected cash flows and/or decrease in the Company’s stock price. Consequently, the Company recorded a non-cash goodwill impairment charge of $45.9 million during the year ended December 31, 2022.

 

The following table presents the carrying amounts of goodwill attributable to each of the Company’s reportable segments (dollars in thousands):
 

   

Branded Products

   

Healthcare Apparel

   

Total

 

As of January 1, 2022:

                       

Gross goodwill

  $ 19,111     $ 20,323     $ 39,434  

Accumulated impairment losses

    -       -       -  

Net goodwill

  $ 19,111     $ -     $ 39,434  
                         

Additions

  $ 6,463     $ -     $ 6,463  

Impairment charge

    (25,595 )     (20,323 )     (45,918 )

Foreign currency translation

    21       -       21  

Net goodwill, December 31, 2022

  $ -     $ -     $ -  
                         

As of December 31, 2022:

                       

Gross goodwill

  $ 25,595     $ 20,323     $ 45,918  

Accumulated impairment losses

    (25,595 )     (20,323 )     (45,918 )

Net goodwill

  $ -     $ -     $ -  

 

Intangible Assets

 

In conjunction with the Company’s realignment of its reportable segments during the second quarter of 2022, the Company began an effort to centralize certain branding and go-to-market strategies under the BAMKO brand and determined that it would no longer use certain trade names associated with branded products. The Company’s rebranding efforts resulted in a $5.6 million impairment of indefinite-lived trade names related to its Branded Products segment during the year ended December 31, 2022. The carrying amounts of indefinite-lived trade names are summarized as follows (dollars in thousands):

 

Indefinite-lived Intangible Assets

 

Segment

 

Carrying Amount, December 31, 2021

   

Impairment Charges

   

Carrying Amount, December 31, 2022

   

Carrying Amount, December 31, 2023

 

Trade names:

                                   

HPI

 

Branded Products

  $ 4,700     $ -     $ 4,700     $ 4,700  

BAMKO

 

Branded Products

    8,900       -       8,900       8,900  

Public Identity

 

Branded Products

    470       (470 )     -       -  

Tangerine

 

Branded Products

    3,200       (3,200 )     -       -  

Gifts By Design

 

Branded Products

    1,170       (1,170 )     -       -  

Sutter’s Mill

 

Branded Products

    741       (741 )     -       -  

CID Resources(1)

 

Healthcare Apparel

    14,160       -       14,160       14,160  

Total

  $ 33,341     $ (5,581 )   $ 27,760     $ 27,760  

 

(1) Includes trade names and trademarks associated with CID Resources, Wink™ and Zoey and Chloe.

 

Intangible assets as of December 31, 2023 and December 31, 2022 are summarized as follows (dollars in thousands):

 

           

December 31, 2023

   

December 31, 2022

 

Item

 

Weighted Average Life (In years)

   

Gross Carrying Amount

   

Accumulated Amortization

   

Gross Carrying Amount

   

Accumulated Amortization

 

Definite-lived intangible assets:

                                       

Customer relationships (7-15 year life)

    11.7     $ 50,198     $ (27,417 )   $ 50,198     $ (23,330 )

Non-compete agreements (3-7 year life)

    5.4       1,712       (1,507 )     1,712       (1,367 )

Trademarks

    10.0       414       (118 )     379       (72 )

Trade names

    2.0       710       (592 )     710       (237 )

Total

          $ 53,034     $ (29,634 )   $ 52,999     $ (25,006 )
                                         

Indefinite-lived intangible assets:

                                       

Trade names

          $ 27,760             $ 27,760          
                                 

Total intangible assets

          $ 80,794     $ (29,634 )   $ 80,759     $ (25,006 )

 

Amortization expense for intangible assets for the years ended December 31, 2023 and 2022 was $4.6 million and $5.1 million, respectively.

 

Estimated future intangible amortization expense is as follows (in thousands):

 

2024

  $ 3,719  

2025

    3,069  

2026

    3,061  

2027

    3,020  

2028

    2,671  

Thereafter

    7,860  

Total

  $ 23,400